Search

Your search keyword '"Hepatocellular carcinoma -- Prognosis -- Care and treatment"' showing total 78 results
Start Over Descriptor "Hepatocellular carcinoma -- Prognosis -- Care and treatment"
78 results on '"Hepatocellular carcinoma -- Prognosis -- Care and treatment"'

1. Medical University of Warsaw Researchers Add New Study Findings to Research in Liver Cancer (Prognostic factors for hepatocellular carcinoma recurrence after liver transplantation or resection - single-center experience)

Subjects
Care and treatment, Analysis, Prognosis, Reports, Surgery -- Reports -- Analysis, Hepatocellular carcinoma -- Prognosis -- Care and treatment, Recurrence (Disease) -- Care and treatment -- Prognosis, Cancer research -- Reports -- Analysis, Liver transplantation -- Reports -- Analysis, Oncology, Experimental -- Reports -- Analysis, Diseases -- Relapse, Liver -- Transplantation, Hepatoma -- Prognosis -- Care and treatment, Cancer -- Research
Abstract

2024 DEC 14 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- New research on liver cancer is the subject of a new report. [...]

Published
2024

2. Guangxi Medical University Cancer Hospital Researchers Focus on Liver Cancer (Prognostic importance of the Scottish inflammatory prognostic score in patients with hepatocellular carcinoma after hepatectomy: a retrospective cohort study)

Subjects
Care and treatment, Analysis, Prognosis, Cancer treatment -- Analysis, Hepatocellular carcinoma -- Prognosis -- Care and treatment, Cancer research -- Analysis, Cancer patients -- Prognosis -- Care and treatment, Oncology, Experimental -- Analysis, Cancer -- Care and treatment -- Research, Hepatoma -- Prognosis -- Care and treatment
Abstract

2024 DEC 7 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Fresh data on liver cancer are presented in a new report. According [...]

Published
2024

3. Findings on Liver Cancer Reported by Investigators at Tianjin Institute of Hepatobiliary Disease (Alterations In Serum Metabolic Profiles of Early-stage Hepatocellular Carcinoma Patients After Radiofrequency Ablation Therapy)

Subjects
Care and treatment, Prognosis, Reports, Physical fitness -- Reports, Diseases -- Prognosis -- Care and treatment -- China, Hepatocellular carcinoma -- Prognosis -- Care and treatment, Ablation (Surgery) -- Reports, Amino acids -- Reports, Hepatoma -- Prognosis -- Care and treatment
Abstract

2024 JUN 22 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Research findings on Oncology - Liver Cancer are discussed in a new [...]

Published
2024

4. Prediction of local tumor progression after microwave ablation for early-stage hepatocellular carcinoma with machine learning

Author

Ren, He, An, Chao, Fu, Wanxi, Wu, Jingyan, Yao, Wenhuan, Yu, Jie, and Liang, Ping

Subjects
Care and treatment, Usage, Prognosis, Patient outcomes, Methods, Machine learning -- Usage, Hepatocellular carcinoma -- Prognosis -- Care and treatment, Ablation (Surgery) -- Methods -- Patient outcomes, Microwaves -- Usage, Hepatoma -- Prognosis -- Care and treatment
Abstract

Author(s): He Ren [1,2]; Chao An [2]; Wanxi Fu [1]; Jingyan Wu [3]; Wenhuan Yao [1]; Jie Yu (corresponding author) [2]; Ping Liang (corresponding author) [2] INTRODUCTION Hepatocellular carcinoma (HCC) [...], Objectives: Local tumor progression (LTP) is a major constraint for achieving technical success in microwave ablation (MWA) for the treatment of early-stage hepatocellular carcinoma (EHCC). This study aims to develop machine learning (ML)-based predictive models for LTP after initial MWA in EHCC. Materials and Methods: A total of 607 treatment-naïve EHCC patients (mean ± standard deviation [SD] age, 57.4 ± 10.8 years) with 934 tumors according to the Milan criteria who subsequently underwent MWA between August 2009 and January 2016 were enrolled. During the same period, 299 patients were assigned to the external validation datasets. To identify risk factors of LTP after MWA, clinicopathological data and ablation parameters were collected. Predictive models were developed according to 21 variables using four ML algorithms and evaluated based on the area under the receiver operating characteristic curve (AUC) with 95 confidence intervals (CIs). Results: After a median follow-up time of 28.7 months (range, 7.6-110.5 months), 6.9 (42/607) of patients had confirmed LTP in the training dataset. The tumor size and number were significantly related to LTP. The AUCs of the four models ranged from 0.791 to 0.898. The best performance (AUC: 0.898, 95 CI: [0.842 0.954]; SD: 0.028) occurred when nine variables were introduced to the CatBoost algorithm. According to the feature selection algorithms, the top six predictors were tumor number, albumin and alpha-fetoprotein, tumor size, age, and international normalized ratio. Conclusions: Out of the four ML models, the CatBoost model performed best, and reasonable and precise ablation protocols will significantly reduce LTP. Keywords: CatBoost, hepatocellular carcinoma, local tumor progression, machine learning, microwave ablation

Published
2023
Full Text
View/download PDF

5. New Liver Cancer Study Results from Shenzhen University Described (Engineered Exosomes Loaded With M1-8 Peptide for Targeted Therapy of Hepatocellular Carcinoma)

Subjects
Care and treatment, Evaluation, Prognosis, Mortality -- Evaluation -- China, Hepatocellular carcinoma -- Prognosis -- Care and treatment, Hepatoma -- Prognosis -- Care and treatment
Abstract

2024 APR 27 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on Oncology - Liver Cancer have been published. According [...]

Published
2024

6. New Liver Cancer Data Have Been Reported by Researchers at National Institute of Pharmaceutical Education and Research (L-methionine Potentiates Anticancer Activity of Sorafenib By Epigenetically Altering Dusp3/erk Pathway In Hepatocellular ...)

Subjects
Care and treatment, Complications and side effects, Prognosis, Patient outcomes, Health aspects, Hepatocellular carcinoma -- Prognosis -- Care and treatment, Methionine -- Health aspects, Sorafenib -- Complications and side effects -- Patient outcomes, Hepatoma -- Prognosis -- Care and treatment
Abstract

2024 MAR 23 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Researchers detail new data in Oncology - Liver Cancer. According to news [...]

Published
2024

7. Studies from Capital Medical University Further Understanding of Liver Cancer (Prognostic value of the neutrophil-to-lymphocyte ratio and prognostic nutritional index in unresectable hepatocellular carcinoma patients treated with tyrosine ...)

Subjects
Care and treatment, Prognosis, Lymphocytes, Hepatocellular carcinoma -- Prognosis -- Care and treatment, Cancer research, Tyrosine, Lenvatinib, Phenols (Class of compounds), Medical schools, Oncology, Experimental, Phenols, Medical colleges, Hepatoma -- Prognosis -- Care and treatment, Cancer -- Research
Abstract

2025 JAN 3 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Investigators publish new report on liver cancer. According to news originating from Beijing, [...]

Published
2025

8. Study Results from Shanghai Jiao Tong University School of Medicine Broaden Understanding of Liver Cancer (Prognostic Value of Combined Neutrophil-to-Lymphocyte Ratio and Imaging Tumor Capsule in Solitary Hepatocellular Carcinoma Patients after ...)

Subjects
Care and treatment, Usage, Prognosis, Health aspects, Lymphocytes -- Health aspects, Diagnostic imaging -- Usage, Hepatocellular carcinoma -- Prognosis -- Care and treatment, Cancer research, White blood cell count -- Usage, Neutrophils -- Health aspects, Oncology, Experimental, Blood cell count -- Usage, Cancer -- Research, Hepatoma -- Prognosis -- Care and treatment
Abstract

2024 JAN 27 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on liver cancer have been published. According to news [...]

Published
2024

9. Reports Outline Liver Cancer Study Findings from Shinshu University School of Medicine (Prognostic Significance of C-Reactive Protein in Lenvatinib-Treated Unresectable Hepatocellular Carcinoma: A Multi-Institutional Study)

Subjects
Care and treatment, Analysis, Measurement, Prognosis, Dosage and administration, Health aspects, Hepatocellular carcinoma -- Prognosis -- Care and treatment, C-reactive protein -- Measurement -- Health aspects, Lenvatinib -- Dosage and administration, Biological markers -- Analysis, Hepatoma -- Prognosis -- Care and treatment
Abstract

2023 DEC 2 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators publish new report on liver cancer. According to news reporting originating [...]

Published
2023

10. Studies from Department of Gastroenterology Update Current Data on Hepatitis B Virus (Association of Hypoxia-inducible Factor 1α Expression With Susceptibility To Hepatitis B Virus-related Hepatocellular Carcinoma: a Meta-analysis)

Subjects
Control, Identification and classification, Care and treatment, Complications and side effects, Prognosis, Health aspects, Hepatitis B virus -- Identification and classification -- Control, Anoxia -- Complications and side effects, Hepatocellular carcinoma -- Prognosis -- Care and treatment, Carcinogenesis -- Health aspects, Hypoxia -- Complications and side effects, Hepatoma -- Prognosis -- Care and treatment
Abstract

2023 NOV 11 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- New research on Liver Diseases and Conditions - Hepatitis B Virus is [...]

Published
2023

11. Researcher at Fondazione Policlinico Universitario A. Gemelli IRCCS Discusses Research in Liver Cancer (Prognostic role of radiomics-based body composition analysis for the 1-year survival for hepatocellular carcinoma patients)

Subjects
Care and treatment, Measurement, Prognosis, Dosage and administration, Health aspects, Body composition -- Health aspects, Hepatocellular carcinoma -- Prognosis -- Care and treatment, Sorafenib -- Dosage and administration, Adipose tissue -- Measurement -- Health aspects
Abstract

2023 SEP 9 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators publish new report on liver cancer. According to news reporting originating [...]

Published
2023

12. Studies from Guangxi Medical University Cancer Hospital Provide New Data on Liver Cancer (Radiotherapy plus anti-PD1 versus radiotherapy for hepatic toxicity in patients with hepatocellular carcinoma)

Subjects
Care and treatment, Prognosis, Apoptosis, Physical fitness, Cancer -- Prognosis -- Care and treatment, Hepatocellular carcinoma -- Prognosis -- Care and treatment, Cancer research, Toxicity, Radiotherapy, Oncology, Experimental, Cancer -- Prognosis -- Care and treatment -- Research, Hepatoma -- Prognosis -- Care and treatment
Abstract

2023 AUG 26 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Fresh data on liver cancer are presented in a new report. According [...]

Published
2023

13. Data on Liver Cancer Published by Researchers at First Affiliated Hospital of Guangzhou Medical University (Enhancing prognostic prediction in hepatocellular carcinoma post-TACE: a machine learning approach integrating radiomics and clinical ...)

Subjects
Care and treatment, Prognosis, Data warehousing/data mining, Data mining, Machine learning, Hepatocellular carcinoma -- Prognosis -- Care and treatment, Cancer research, Oncology, Experimental, Cancer -- Research, Hepatoma -- Prognosis -- Care and treatment
Abstract

2024 AUG 2 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Data detailed on liver cancer have been presented. According to news reporting out [...]

Published
2024

14. Researchers at Guangxi Medical University Report New Data on Liver Cancer (Evaluation of the Up-to-7 Criterion for Determining the Treatment of Hepatocellular Carcinoma In Barcelona Clinic Liver Cancer Stage B: a Single-center Retrospective ...)

Subjects
Quality management, Care and treatment, Prognosis, Methods, Cancer treatment -- Quality management, Hepatocellular carcinoma -- Prognosis -- Care and treatment, Cancer staging -- Methods, Cancer -- Care and treatment, Tumor staging -- Methods, Hepatoma -- Prognosis -- Care and treatment
Abstract

2023 MAY 27 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators publish new report on Oncology - Liver Cancer. According to news [...]

Published
2023

15. Keelung Chang Gung Memorial Hospital Researchers Highlight Research in Chronic Kidney Disease (Should we change the treatment plan in early hepatocellular carcinoma with chronic kidney disease?)

Subjects
Care and treatment, Prognosis, Physical fitness, Cancer -- Prognosis -- Care and treatment, Hepatocellular carcinoma -- Prognosis -- Care and treatment, Medical research, Chronic kidney failure -- Prognosis -- Care and treatment, Medicine, Experimental, Hepatoma -- Prognosis -- Care and treatment
Abstract

2023 MAY 6 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Data detailed on chronic kidney disease have been presented. According to news [...]

Published
2023

16. Data on Liver Cancer Discussed by Researchers at Affiliated Hospital of Qingdao University (Adjuvant transarterial chemoembolization timing after radical resection is an independent prognostic factor for patients with hepatocellular carcinoma)

Subjects
Care and treatment, Prognosis, Surgery, Cancer -- Prognosis -- Care and treatment, Hepatocellular carcinoma -- Prognosis -- Care and treatment, Cancer research, Oncology, Experimental, Cancer -- Prognosis -- Care and treatment -- Research, Hepatoma -- Prognosis -- Care and treatment
Abstract

2023 APR 1 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Data detailed on liver cancer have been presented. According to news reporting [...]

Published
2023

17. JW Therapeutics begins clinical study of JWATM214 in patients with advanced hepatocellular carcinoma

Subjects
Care and treatment, Prognosis, Clinical trials, Hepatocellular carcinoma -- Prognosis -- Care and treatment, Medical research, Medicine, Experimental, Hepatoma -- Prognosis -- Care and treatment
Abstract

JW Therapeutics, an independent and innovative biotechnology company, announced the initiation of clinical study of JWATM214 in patients with advanced hepatocellular carcinoma (HCC) and the first patient infusion. Primary hepatic [...]

Published
2023

18. New Findings in Liver Cancer Described from National Hospital Organization Shikoku Cancer Center (Efficacy and Safety of Three-dimensional Conformal Radiotherapy for Macroscopic Vascular Invasion of Hepatocellular Carcinoma)

Subjects
Care and treatment, Analysis, Prognosis, Cancer treatment -- Analysis, Physical fitness -- Analysis, Hepatocellular carcinoma -- Prognosis -- Care and treatment, Medical research -- Analysis, Radiotherapy -- Analysis, Medicine, Experimental -- Analysis, Cancer -- Care and treatment, Hepatoma -- Prognosis -- Care and treatment
Abstract

2023 FEB 11 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on Oncology - Liver Cancer have been published. According [...]

Published
2023

19. Researchers at Department of Hepatobiliary Surgery Target Liver Cancer (Prognostic value of LncRNA-HOTAIR for patients with hepatocellular carcinoma: a meta-analysis)

Subjects
Care and treatment, Analysis, Prognosis, Surgery -- Analysis, Cancer -- Prognosis -- Care and treatment, Hepatocellular carcinoma -- Prognosis -- Care and treatment, Cancer research -- Analysis, Oncology, Experimental -- Analysis, Cancer -- Prognosis -- Care and treatment -- Research, Hepatoma -- Prognosis -- Care and treatment
Abstract

2022 DEC 24 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on liver cancer have been published. According to news [...]

Published
2022

20. Affiliated Cancer Hospital of Zhengzhou University Researchers Broaden Understanding of Liver Cancer (Proteoglycan-4 predicts good prognosis in patients with hepatocellular carcinoma receiving transcatheter arterial chemoembolization and ...)

Subjects
Care and treatment, Research, Prognosis, Patient outcomes, Health aspects, Hepatocellular carcinoma -- Prognosis -- Care and treatment, Cancer research, Proteoglycans -- Health aspects, Cell migration -- Research, Therapeutic chemoembolization -- Patient outcomes, Oncology, Experimental, Cancer -- Research, Hepatoma -- Prognosis -- Care and treatment
Abstract

2022 DEC 3 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Researchers detail new data in liver cancer. According to news reporting originating [...]

Published
2022

21. Researchers' Work from Capital Medical University Focuses on Liver Cancer (Prognostic value of CD8+T cells related genes and exhaustion regulation of Notch signaling pathway in hepatocellular carcinoma)

Subjects
Care and treatment, Prognosis, Genetic research, Cancer genetics -- Care and treatment -- Prognosis, Hepatocellular carcinoma -- Prognosis -- Care and treatment, Cancer research, Genes, Fatigue -- Care and treatment -- Prognosis, Immunotherapy, T cells, Oncology, Experimental, Cancer -- Genetic aspects -- Research, Hepatoma -- Prognosis -- Care and treatment
Abstract

2024 APR 24 (NewsRx) -- By a News Reporter-Staff News Editor at Immunotherapy Weekly -- Current study results on liver cancer have been published. According to news reporting from Beijing, [...]

Published
2024

22. Research from Capital Medical University Broadens Understanding of Liver Cancer (Clinical prognosis of intraoperative blood salvage autotransfusion in liver transplantation for hepatocellular carcinoma: A systematic review and meta-analysis)

Subjects
Care and treatment, Prognosis, Patient outcomes, Methods, Hepatocellular carcinoma -- Prognosis -- Care and treatment, Liver transplantation -- Methods, Autologous blood transfusion -- Patient outcomes, Liver -- Transplantation, Hepatoma -- Prognosis -- Care and treatment, Blood transfusion, Autologous -- Patient outcomes
Abstract

2022 NOV 5 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators discuss new findings in liver cancer. According to news reporting originating [...]

Published
2022

23. Second Xiangya Hospital of Central South University Researchers Further Understanding of Disease-Free Survival (Identification of the Immune Subtype of Hepatocellular Carcinoma for the Prediction of Disease-Free Survival Time and Prevention of ...)

Subjects
Care and treatment, Prevention, Usage, Prognosis, Risk factors, Health aspects, White blood cells -- Health aspects, Cancer recurrence -- Risk factors -- Prevention, Hepatocellular carcinoma -- Prognosis -- Care and treatment, Cancer research, RNA sequencing -- Usage, Statistical models -- Usage, Oncology, Experimental, Cancer -- Relapse -- Research, Hepatoma -- Prognosis -- Care and treatment, Leukocytes -- Health aspects
Abstract

2022 JUN 25 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- New research on disease-free survival is the subject of a new report. [...]

Published
2022

24. Research Conducted at University of Queensland Has Provided New Information about Liver Cancer (Long-term Survival and Postoperative Complications of Pre-liver Transplantation Transarterial Chemoembolisation In Hepatocellular Carcinoma: a ...)

Subjects
Care and treatment, Complications and side effects, Prognosis, Hepatocellular carcinoma -- Prognosis -- Care and treatment, Therapeutic chemoembolization -- Complications and side effects, Hepatoma -- Prognosis -- Care and treatment
Abstract

2022 JUN 25 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- New research on Oncology - Liver Cancer is the subject of a [...]

Published
2022

25. Acute kidney injury following resection of hepatocellular carcinoma: prognostic value of the acute kidney injury network criteria

Author

Bressan, Alexsander K., James, Matthew T., Dixon, Elijah, Bathe, Oliver F., Sutherland, Francis R., and Ball, Chad G.

Subjects
Care and treatment, Prognosis, Patient outcomes, Excision (Surgery) -- Patient outcomes, Acute kidney failure -- Care and treatment, Hepatocellular carcinoma -- Prognosis -- Care and treatment
Abstract

Postoperative acute kidney injury (AKI) is reported in approximately 15% of patients undergoing liver resections, and is associated with increased morbidity and mortality. (1-3) Multiple predisposing factors have been described, [...], Background: Acute kidney injury (AKI) is associated with increased morbidity and mortality after liver resection. Patients with hepatocellular carcinoma (HCC) have a higher risk of AKI owing to the underlying association between hepatic and renal dysfunction. Use of the Acute Kidney Injury Network (AKIN) diagnostic criteria is recommended for patients with cirrhosis, but remains poorly studied following liver resection. We compared the prognostic value of the AKIN creatinine and urine output criteria in terms of postoperative outcomes following liver resection for HCC. Methods: All patients who underwent a liver resection for HCC from January 2010 to June 2016 were included. We used AKIN urine output and creatinine criteria to assess for AKI within 48 hours of surgery. Results: Eighty liver resections were performed during the study period. Cirrhosis was confirmed in 80%. Median hospital stay was 9 (interquartile range 7-12) days, and 30-day mortality was 2.5%. The incidence of AKI was higher based on the urine output than on the creatinine criterion (53.8% v. 20%), and was associated with prolonged hospitalization and 30-day postoperative mortality when defined by serum creatinine (hospital stay: 11.2 v. 20.1 d, p = 0.01; mortality: 12.5% v. 0%, p < 0.01), but not urine output (hospital stay: 15.6 v. 10 d, p = 0.05; mortality: 2.3% v. 2.7%, p > 0.99). Conclusion: The urine output criterion resulted in an overestimation of AKI and compromised the prognostic value of AKIN criteria. Revision may be required to account for the exacerbated physiologic postoperative reduction in urine output in patients with HCC. Contexte : L&apos;insuffisance renale aigue (IRA) est associee a une morbidite et a une mortalite accrues apres une resection hepatique. Les patients atteints d&apos;un carcinome hepatocellulaire (CHC) sont exposes a un risque plus grand d&apos;IRA en raison du lien sous-jacent entre l&apos;insuffisance hepatique et l&apos;insuffisance renale. Les criteres diagnostiques de l&apos;Acute Kidney Injury Network (AKIN) sont recommandes chez les patients cirrhotiques, mais ils n&apos;ont pas ete bien etudies dans les cas de resection hepatique. Nous avons compare la valeur pronostique des criteres de l&apos;AKIN tels que la creatinine et le debit urinaire pour ce qui est des resultats postoperatoires suite a une resection hepatique pour CHC. Methodes : Tous les patients soumis a une resection hepatique pour CHC entre janvier 2010 et juin 2016 ont ete inclus. Nous avons utilise les criteres de l&apos;AKIN concernant le debit urinaire et la creatinine pour evaluer l&apos;IRA dans les 48 heures suivant la chirurgie. Resultats : Quatre-vingt resections hepatiques ont ete effectuees pendant la periode de l&apos;etude. La cirrhose a ete confirmee dans 80 % des cas. Le sejour hospitalier median a dure 9 jours (intervalle interquartile 7-12 jours) et la mortalite a 30 jours a ete de 2,5 %. L&apos;incidence de l&apos;IRA a ete plus elevee selon le critere debit urinaire que selon le critere creatinine (53,8 % c. 20 %), et a ete associee a un sejour plus long et a une mortalite a 30 jours plus elevee suite a l&apos;intervention selon le critere creatinine serique (sejour hospitalier : 11,2 c. 20,1 j, p = 0,01; mortalite : 12,5 % c. 0 %, p < 0,01), mais non selon le critere debit urinaire (sejour hospitalier : 15,6 c. 10 j, p = 0,05; mortalite : 2,3 % c. 2,7 %, p > 0,99). Conclusion : Le critere debit urinaire a donne lieu a une surestimation de l&apos;IRA et a reduit la valeur pronostique des criteres de l&apos;AKIN. Une revision serait peut-etre necessaire pour tenir compte de la reduction physiologique plus marquee du debit urinaire en periode postoperatoire chez les patients atteints d&apos;un CHC.

Published
2018
Full Text
View/download PDF

26. Research from Second Affiliated Hospital of Guangzhou University of Chinese Medicine Provides New Data on Liver Cancer (Prognostic and metabolic characteristics of a novel cuproptosis-related signature in patients with hepatocellular carcinoma)

Subjects
Care and treatment, Prognosis, Apoptosis, Hepatocellular carcinoma -- Prognosis -- Care and treatment, Asian medicine, Medicine, Oriental, Hepatoma -- Prognosis -- Care and treatment
Abstract

2024 JAN 19 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Current study results on liver cancer have been published. According to news reporting [...]

Published
2024

27. Data on Liver Cancer Discussed by Researchers at University of Strasbourg (Inflammation-related prognostic markers in resected hepatocellular carcinoma)

Subjects
University of Strasbourg, Care and treatment, Prognosis, Inflammation -- Care and treatment -- Prognosis, Hepatocellular carcinoma -- Prognosis -- Care and treatment, Cancer research, Oncology, Experimental, Cancer -- Research, Hepatoma -- Prognosis -- Care and treatment
Abstract

2023 DEC 26 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Investigators discuss new findings in liver cancer. According to news reporting originating from Strasbourg, France, [...]

Published
2023

28. Data on Liver Cancer Described by Researchers at University of Tokyo (Machine Learning-Based Personalized Prediction of Hepatocellular Carcinoma Recurrence After Radiofrequency Ablation)

Subjects
University of Tokyo, Care and treatment, Prognosis, Physical fitness, Machine learning, Cancer -- Prognosis -- Care and treatment, Hepatocellular carcinoma -- Prognosis -- Care and treatment, Cancer research, Ablation (Surgery), Oncology, Experimental, Cancer -- Prognosis -- Care and treatment -- Research, Hepatoma -- Prognosis -- Care and treatment
Abstract

2022 APR 23 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on liver cancer have been published. According to news [...]

Published
2022

29. Neutrophil-to-lymphocyte Ratio (NLR) as an Index of Response to Treatment in Patients with Hepatocellular Carcinoma after Receiving Trans-arterial Chemoembolization (TACE)

Subjects
Care and treatment, Prognosis, Lymphocytes, Hepatocellular carcinoma -- Prognosis -- Care and treatment, Medical research, Medicine, Experimental, Hepatoma -- Prognosis -- Care and treatment
Abstract

2023 JUN 2 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- According to news reporting based on a preprint abstract, our journalists obtained the [...]

Published
2023

30. Data on Liver Cancer Published by Researchers at Guizhou University of Traditional Chinese Medicine (Cell Division Cycle Associated Genes as Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma)

Subjects
Care and treatment, Prognosis, Reports, Cancer genetics -- Prognosis -- Care and treatment, B cells -- Reports, Hepatocellular carcinoma -- Prognosis -- Care and treatment, Cancer research -- Reports, Genes -- Reports, Biochemistry -- Reports, Traditional Chinese medicine -- Reports, Biological markers -- Reports, Oncology, Experimental -- Reports, Medicine, Chinese -- Reports, Cancer -- Genetic aspects -- Research, Hepatoma -- Prognosis -- Care and treatment
Abstract

2021 APR 3 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators publish new report on liver cancer. According to news originating from [...]

Published
2021

31. Zhejiang University Reports Findings in Liver Cancer (Prognostic Value of Low Skeletal Muscle Mass In Hepatocellular Carcinoma Patients Treated With Sorafenib or Lenvatinib: a Meta-analysis)

Subjects
Care and treatment, Analysis, Prognosis, Hepatocellular carcinoma -- Prognosis -- Care and treatment, Skeletal muscle -- Analysis, Medical research -- Analysis, Sorafenib -- Analysis, Lenvatinib -- Analysis, Medicine, Experimental -- Analysis, Hepatoma -- Prognosis -- Care and treatment, Muscles -- Analysis
Abstract

2021 FEB 27 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Data detailed on Oncology - Liver Cancer have been presented. According to [...]

Published
2021

32. Researchers at Affiliated Hospital of Qingdao University Target Liver Cancer (Development and Validation of Nomograms Based on Gamma-Glutamyl Transpeptidase to Platelet Ratio for Hepatocellular Carcinoma Patients Reveal Novel Prognostic Value ...)

Subjects
Care and treatment, Analysis, Prognosis, Health aspects, Hepatocellular carcinoma -- Prognosis -- Care and treatment, Cancer research -- Health aspects -- Analysis, Oncology, Experimental -- Health aspects -- Analysis, Cancer -- Research, Hepatoma -- Prognosis -- Care and treatment
Abstract

2021 JAN 9 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Data detailed on Oncology - Liver Cancer have been presented. According to [...]

Published
2021

33. Data from Princess Margaret Cancer Centre Advance Knowledge in Liver Cancer (Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma with Macrovascular Invasion)

Subjects
Care and treatment, Prognosis, Physical fitness, Hepatocellular carcinoma -- Prognosis -- Care and treatment, Radiotherapy, Sorafenib, Radiation (Physics), Radiation, Hepatoma -- Prognosis -- Care and treatment
Abstract

2020 DEC 26 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Data detailed on Oncology - Liver Cancer have been presented. According to [...]

Published
2020

34. Findings on Muscular Atrophy Reported by Researchers at Tianjin Fifth Central Hospital (Preoperative computed tomography-assessed skeletal muscle index is a novel prognostic factor in patients with hepatocellular carcinoma following ...)

Subjects
Care and treatment, Prognosis, Reports, Skeletal muscle -- Reports, Hepatocellular carcinoma -- Prognosis -- Care and treatment, Muscular atrophy -- Care and treatment -- Prognosis, CAT scans -- Reports
Abstract

2020 DEC 5 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators publish new report on Musculoskeletal Diseases and Conditions - Muscular Atrophy. [...]

Published
2020

35. Findings on Liver Cancer Detailed by Investigators at Sun Yat-sen University (Novel Prognostic Scores Based On Serum Ferritin/globulin Ratio In Patients With Hepatocellular Carcinoma)

Subjects
Care and treatment, Prognosis, Reports, Hepatocellular carcinoma -- Prognosis -- Care and treatment, Ferritin -- Reports
Abstract

2020 DEC 5 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- A new study on Oncology - Liver Cancer is now available. According [...]

Published
2020

36. Data on Small Hepatocellular Cancer Discussed by Researchers at Wakayama Medical University (Prognostic value of 18F-fluorodeoxyglucose positron emission tomography in patients with small hepatocellular carcinoma treated by radiofrequency ...)

Subjects
Care and treatment, Prognosis, Positron emission tomography, Hepatocellular carcinoma -- Prognosis -- Care and treatment, Cancer research
Abstract

2020 NOV 7 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators publish new report on Oncology - Small Hepatocellular Cancer. According to [...]

Published
2020

37. Chugai obtains Japanese approval for additional indication of Tecentriq and Avastin to treat unresectable hepatocellular carcinoma

Subjects
Tecentriq (Medication), Avastin (Medication), Care and treatment, Prognosis, Atezolizumab, Hepatocellular carcinoma -- Prognosis -- Care and treatment, Bevacizumab, Vascular endothelial growth factor, Sorafenib
Abstract

Chugai Pharmaceutical announced that it obtained approval for an additional indication of Tecentriq Intravenous Infusion 1,200 mg [generic name: atezolizumab (genetical recombination)], an anti-cancer agent/humanized anti-PD-L1 monoclonal antibody, and Avastin [...]

Published
2020

40. Findings on Liver Cancer Reported by Investigators at Lishui Central Hospital [Radiofrequency Ablation (Rfa) Combined With Transcatheter Arterial Chemoembolization (Tace) for Patients With Medium-to-large Hepatocellular Carcinoma: a ...]

Subjects
Care and treatment, Prognosis, Physical fitness, Hepatocellular carcinoma -- Prognosis -- Care and treatment, Ablation (Surgery)
Abstract

2020 AUG 15 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators publish new report on Oncology - Liver Cancer. According to news [...]

Published
2020

41. New Findings from National Cancer Center Hospital East in Liver Cancer Provides New Insights (Impact of Proton Beam Irradiation of an Anatomic Subsegment of the Liver for Hepatocellular Carcinoma)

Subjects
Care and treatment, Analysis, Prognosis, Reports, Cancer treatment -- Reports -- Analysis, Physical fitness -- Reports -- Analysis, Hepatocellular carcinoma -- Prognosis -- Care and treatment
Abstract

2020 AUG 8 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators publish new report on Oncology - Liver Cancer. According to news [...]

Published
2020

42. Data on Liver Cancer Described by Researchers at Princess Alexandra Hospital (Stereotactic radiotherapy for hepatocellular carcinoma: Expanding the multidisciplinary armamentarium)

Subjects
Care and treatment, Prognosis, Physical fitness, Hepatocellular carcinoma -- Prognosis -- Care and treatment, Cancer research, Radiotherapy
Abstract

2020 JUL 25 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on Oncology - Liver Cancer have been published. According [...]

Published
2020

43. Stanford University Researchers Detail New Studies and Findings in the Area of Liver Cancer (OSlihc: An Online Prognostic Biomarker Analysis Tool for Hepatocellular Carcinoma)

Subjects
Stanford University -- Reports, Care and treatment, Prognosis, Reports, Hepatocellular carcinoma -- Prognosis -- Care and treatment, Cancer research -- Reports, Gene expression -- Reports, Biological markers -- Reports
Abstract

2020 JUN 27 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators publish new report on liver cancer. According to news reporting out [...]

Published
2020

44. Reports from First Affiliated Hospital of Nanjing Medical University Advance Knowledge in Liver Cancer (Prognostic value of precise hepatic pedicle dissection in anatomical resection for patients with hepatocellular carcinoma)

Subjects
Care and treatment, Prognosis, Surgery, Hepatocellular carcinoma -- Prognosis -- Care and treatment, Obesity, Liver cancer, Carcinoma, Cancer, Editors
Abstract

2020 MAR 28 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on Oncology - Liver Cancer have been published. According [...]

Published
2020

45. Data on Solid Cancer Detailed by a Researcher at Hiroshima University (Evaluation of Response to Atezolizumab Plus Bevacizumab in Patients with Advanced Hepatocellular Carcinoma Using the Combination of Response Evaluation Criteria in Solid ...)

Subjects
Hiroshima University -- Reports, Care and treatment, Analysis, Prognosis, Reports, Hepatocellular carcinoma -- Prognosis -- Care and treatment, Atezolizumab -- Analysis -- Reports, Bevacizumab -- Analysis -- Reports, Cancer research -- Reports -- Analysis, Immunotherapy -- Reports -- Analysis, Oncology, Experimental -- Reports -- Analysis, Hepatoma -- Prognosis -- Care and treatment, Cancer -- Research
Abstract

2023 MAY 3 (NewsRx) -- By a News Reporter-Staff News Editor at Immunotherapy Weekly -- New study results on solid cancer have been published. According to news reporting out of [...]

Published
2023

46. JW Therapeutics Announces Initiation of Clinical Study of JWATM214 in Patients with Advanced Hepatocellular Carcinoma

Subjects
Care and treatment, Prognosis, Clinical trials, Hepatocellular carcinoma -- Prognosis -- Care and treatment, Medical research, Immunotherapy, Medicine, Experimental, Hepatoma -- Prognosis -- Care and treatment
Abstract

2023 MAR 13 (NewsRx) -- By a News Reporter-Staff News Editor at Pharma Business Week -- JW Therapeutics (HKEX: 2126), an independent and innovative biotechnology company focusing on developing, manufacturing [...]

Published
2023

47. Study Findings from Curie Institute Update Knowledge in Liver Cancer (Angiogenesis and immune checkpoint inhibitors as therapies for hepatocellular carcinoma: current knowledge and future research directions)

Subjects
Care and treatment, Prognosis, Cancer treatment, Physical fitness, Neovascularization, Hepatocellular carcinoma -- Prognosis -- Care and treatment, Cancer research, Antineoplastic agents, Obesity, Motor vehicle drivers, Liver cancer, Carcinoma, Cancer, Editors
Abstract

2019 DEC 21 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- New research on liver cancer is the subject of a new report. [...]

Published
2019

48. Researchers at Department of Surgery and Science Target Muscular Atrophy (Comparison of the prognostic effect of sarcopenia on atezolizumab plus bevacizumab and lenvatinib therapy in hepatocellular carcinoma patients)

Subjects
Care and treatment, Prognosis, Comparative analysis, Cancer treatment -- Comparative analysis, Sarcopenia -- Prognosis -- Care and treatment, Surgery -- Comparative analysis, Atezolizumab -- Comparative analysis, Hepatocellular carcinoma -- Prognosis -- Care and treatment, Bevacizumab -- Comparative analysis, Sorafenib -- Comparative analysis, Immunotherapy -- Comparative analysis, Lenvatinib -- Comparative analysis, Cancer -- Care and treatment, Hepatoma -- Prognosis -- Care and treatment
Abstract

2022 JUL 27 (NewsRx) -- By a News Reporter-Staff News Editor at Immunotherapy Weekly -- Investigators discuss new findings in muscular atrophy. According to news originating from the Department of [...]

Published
2022

49. Study Results from University of Texas MD Anderson Cancer Center Update Understanding of Liver Cancer (Quantitative analysis of spatial distribution of lymphocytes in hepatocellular carcinoma: A biomarker correlated with survival and gene ...)

Subjects
University of Texas. M.D. Anderson Cancer Center, Care and treatment, Prognosis, Lymphocytes, Genetic research, Cancer genetics -- Care and treatment -- Prognosis, Hepatocellular carcinoma -- Prognosis -- Care and treatment, Cancer research, Biological markers, Oncology, Experimental, Cancer -- Genetic aspects -- Research, Hepatoma -- Prognosis -- Care and treatment
Abstract

2022 JUL 22 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Investigators publish new report on liver cancer. According to news reporting from Houston, [...]

Published
2022

50. Researchers from Tianjin Medical University Cancer Institute and Hospital Describe Research in Personalized Medicine (A Predictive Nomogram of Early Recurrence for Patients with AFP-Negative Hepatocellular Carcinoma Underwent Curative Resection)

Subjects
Care and treatment, Prognosis, Reports, Precision medicine -- Reports, Cancer -- Prognosis -- Care and treatment, Hepatocellular carcinoma -- Prognosis -- Care and treatment, Cancer research -- Reports, Oncology, Experimental -- Reports, Cancer -- Prognosis -- Care and treatment -- Research, Hepatoma -- Prognosis -- Care and treatment
Abstract

2022 JUN 17 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Research findings on personalized medicine are discussed in a new report. According to [...]

Published
2022

Catalog

Books, media, physical & digital resources
See catalog results